Strategic partnerships Lonza is expanding collaboration efforts in biotech and vaccine development, including a strategic alliance with Ethris and a broader IBM data collaboration. Sales opportunities exist in providing scalable CDMO support, data analytics, and cloud-based process optimization to accelerate vaccine and biologics programs.

Scale and manufacturing As a global leader in CDMO services with long-standing scale, Lonza seeks to improve manufacturing efficiency and speed to market. Opportunities to target for process intensification, lean manufacturing, and automation solutions to reduce cycle times and costs across cell and gene therapy and traditional pharmaceutical manufacturing.

Digital transformation Lonza already uses Azure Databricks, Tableau, Qlik and other analytics tools, signaling a maturity in data-driven operations. Potential sales angles include advanced analytics, data integration, and enterprise workflow automation to optimize supplier management, quality control, and batch release processes.

Compliance and governance Recent leadership appointments in legal and corporate affairs, along with a focus on risk management, indicate emphasis on governance and regulatory compliance. This presents opportunities for enterprise software, risk analytics, and compliance automation solutions tailored to GMP and global supply chains.

Workforce development Lonza is investing in apprenticeships and workforce training, including partnerships with educational institutions. Sales potential exists for workforce upskilling programs, digital training platforms, and manufacturing automation training to support talent pipelines in biomanufacturing and process development.